EB-treated MS rats showed substantially decreased Nrf2 and HO-1 levels in the CSF and homogenate of the rat brain compared to the vehicle, sham, and AKBA 100 mg/kg perse treatment group. Here, HMOX1 is linked to myeloid sarcoma.